This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, P.-P. Articles by Kros, J. M. Search for Related Content PubMed PubMed Citation Articles by Zheng, P.-P. Articles by Kros, J. M.

(American Journal of Pathology. 2004;164:2217-2228.)
© 2004 American Society for Investigative Pathology

Differential Expression of Splicing Variants of the Human Caldesmon Gene (CALD1) in Glioma Neovascularization versus Normal Brain Microvasculature

Ping-Pin Zheng^*, Anieta M. Sieuwerts, Theo M. Luider, M. van der Weiden^*, Peter A.E. Sillevis-Smitt and Johan M. Kros^*

From the Department of Pathology,^*Internal Oncology,Neuro-Oncology and Neurology,Erasmus Medical Center, Rotterdam, The Netherlands

Caldesmon is a cytoskeleton-associated protein which has not yet been related to neoplastic angiogenesis. In this study we investigated the expression of the caldesmon gene (CALD1) splicing variants and the protein expression level in glioma microvessels versus normal brain microvasculature. To exclude sources of splice variant expression from non-vascular components all possible cellular components present in control and glioma samples were pre-screened by laser-capture microdissection followed by RT-PCR before the cohort study. We discovered differential expression of the splicing variants of CALD1 in the tumor microvessels in contrast to normal brain microvasculature. Missplicing of exons 1, 1 + 4, and 1' + 4 of the gene is exclusively found in glioma microvessels. To exclude the possibility that this missplicing results from splice-site mutations, mutation scanning was performed by a coupled in vitro transcription/translation assay (IVTT). No premature stop mutations were traced by the IVTT. The transcriptional changes consequently resulted in up-regulation at the protein expression level. The up-regulated expression of caldesmon was coincident with the down-regulated expression of tight junction proteins (occludin and ZO-1). The results support the notion that missplicing of the CALD1 gene in glioma microvasculature is an independent epigenetic event regulated at the transcriptional level. The event coexists with tight junction (TJ) breakdown of the endothelial cells in glioma microvasculature. The data reveal a novel mechanism contributing to dysfunctionality of glioma neovascularization.

This article has been cited by other articles:

				L. M. Hoffman, C. C. Jensen, S. Kloeker, C.-L. A. Wang, M. Yoshigi, and M. C. Beckerle Genetic ablation of zyxin causes Mena/VASP mislocalization, increased motility, and deficits in actin remodeling J. Cell Biol., February 27, 2006; 172(5): 771 - 782. [Abstract] [Full Text] [PDF]

				M. E. Cuomo, A. Knebel, G. Platt, N. Morrice, P. Cohen, and S. Mittnacht Regulation of Microfilament Organization by Kaposi Sarcoma-associated Herpes Virus-cyclin{middle dot}CDK6 Phosphorylation of Caldesmon J. Biol. Chem., October 28, 2005; 280(43): 35844 - 35858. [Abstract] [Full Text] [PDF]

				P.-P. Zheng, W. C. Hop, P. A.E. Sillevis Smitt, M. J. van den Bent, C. J.J. Avezaat, T. M. Luider, and J. M. Kros Low-Molecular Weight Caldesmon as a Potential Serum Marker for Glioma Clin. Cancer Res., June 15, 2005; 11(12): 4388 - 4392. [Abstract] [Full Text] [PDF]